Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08KSU
|
|||
| Former ID |
DCL001058
|
|||
| Drug Name |
AP12009
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 3 | [1] | |
| Therapeutic Class |
Antisense
|
|||
| Company |
Antisense therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00761280) Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma. U.S. National Institutes of Health. | |||
| REF 2 | Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.